|
1
|
Forouzanfar MH, Foreman KJ, Delossantos
AM, Lozano R, Lopez AD, Murray CJ and Naghavi M: Breast and
cervical cancer in 187 countries between 1980 and 2010: A
systematic analysis. Lancet. 378:1461–1484. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
American Cancer Society: Cervical Cancer.
American Cancer Society; Atlanta, GA: 2013
|
|
3
|
Waggoner SE: Cervical cancer. Lancet.
361:2217–2225. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
He L and Hannon GJ: MicroRNAs: Small RNAs
with a big role in gene regulation. Nat Rev Genet. 5:522–531. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Filipowicz W, Bhattacharyya SN and
Sonenberg N: Mechanisms of post-transcriptional regulation by
microRNAs: Are the answers in sight? Nat Rev Genet. 9:102–114.
2008. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
Mukherji S, Ebert MS, Zheng GX, Tsang JS,
Sharp PA and van Oudenaarden A: MicroRNAs can generate thresholds
in target gene expression. Nat Genet. 43:854–859. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Calin GA and Croce CM: MicroRNA signatures
in human cancers. Nat Rev Cancer. 6:857–866. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Chen L, Li H, Han L, Zhang K, Wang G, Wang
Y, Liu Y, Zheng Y, Jiang T, Pu P, et al: Expression and function of
miR-27b in human glioma. Oncol Rep. 26:1617–1621. 2011.PubMed/NCBI
|
|
9
|
Wang Y, Rathinam R, Walch A and Alahari
SK: ST14 (suppression of tumorigenicity 14) gene is a target for
miR-27b, and the inhibitory effect of ST14 on cell growth is
independent of miR-27b regulation. J Biol Chem. 284:23094–23106.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ishihara T, Seki N, Inoguchi S, Yoshino H,
Tatarano S, Yamada Y, Itesako T, Goto Y, Nishikawa R, Nakagawa M,
et al: Expression of the tumor suppressive miRNA-23b/27b cluster is
a good prognostic marker in clear cell renal cell carcinoma. J
Urol. 192:1822–1830. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Chen C, Ridzon DA, Broomer AJ, Zhou Z, Lee
DH, Nguyen JT, Barbisin M, Xu NL, Mahuvakar VR, Andersen MR, et al:
Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic
Acids Res. 33:e1792005. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhuo L, Liu J, Wang B, Gao M and Huang A:
Differential miRNA expression profiles in hepatocellular carcinoma
cells and drug-resistant sublines. Oncol Rep. 29:555–562. 2013.
|
|
13
|
Shen S, Sun Q, Liang Z, Cui X, Ren X, Chen
H, Zhang X and Zhou Y: A prognostic model of triple-negative breast
cancer based on miR-27b-3p and node status. PLoS One.
9:e1006642014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Mozos A, Catasús L, D'Angelo E, Serrano E,
Espinosa I, Ferrer I, Pons C and Prat J: The FOXO1-miR27 tandem
regulates myometrial invasion in endometrioid endometrial
adenocarcinoma. Hum Pathol. 45:942–951. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Jiang J, Lv X, Fan L, Huang G, Zhan Y,
Wang M and Lu H: MicroRNA-27b suppresses growth and invasion of
NSCLC cells by targeting Sp1. Tumour Biol. 35:10019–10023. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Goto Y, Kojima S, Nishikawa R, Enokida H,
Chiyomaru T, Kinoshita T, Nakagawa M, Naya Y, Ichikawa T and Seki
N: The microRNA-23b/27b/24-1 cluster is a disease progression
marker and tumor suppressor in prostate cancer. Oncotarget.
5:7748–7759. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Findlay VJ, Wang C, Watson DK and Camp ER:
Epithelial-to-mesenchymal transition and the cancer stem cell
phenotype: Insights from cancer biology with therapeutic
implications for colorectal cancer. Cancer Gene Ther. 21:181–187.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Cai ZG, Zhang SM, Zhang H, Zhou YY, Wu HB
and Xu XP: Aberrant expression of microRNAs involved in
epithelial-mesenchymal transition of HT-29 cell line. Cell Biol
Int. 37:669–674. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Susuki D, Kimura S, Naganuma S, Tsuchiyama
K, Tanaka T, Kitamura N, Fujieda S and Itoh H: Regulation of
microRNA expression by hepatocyte growth factor in human head and
neck squamous cell carcinoma. Cancer Sci. 102:2164–2171. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Park YT, Jeong JY, Lee MJ, Kim KI, Kim TH,
Kwon YD, Lee C, Kim OJ and An HJ: MicroRNAs overexpressed in
ovarian ALDH1-positive cells are associated with chemoresistance. J
Ovarian Res. 6:182013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Mu W, Hu C, Zhang H, Qu Z, Cen J, Qiu Z,
Li C, Ren H, Li Y, He X, et al: miR-27b synergizes with anticancer
drugs via p53 activation and CYP1B1 suppression. Cell Res.
25:477–495. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Nakajima G, Patino-Garcia A, Bruheim S, Xi
Y, San Julian M, Lecanda F, Sierrasesumaga L, Müller C, Fodstad O
and Ju J: CDH11 expression is associated with survival in patients
with osteosarcoma. Cancer Genomics Proteomics. 5:37–42.
2008.PubMed/NCBI
|
|
23
|
Marino N, Collins JW, Shen C, Caplen NJ,
Merchant AS, Gökmen-Polar Y, Goswami CP, Hoshino T, Qian Y, Sledge
GW Jr, et al: Identification and validation of genes with
expression patterns inverse to multiple metastasis suppressor genes
in breast cancer cell lines. Clin Exp Metastasis. 31:771–786. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Delic S, Lottmann N, Jetschke K,
Reifenberger G and Riemenschneider MJ: Identification and
functional validation of CDH11, PCSK6 and SH3GL3 as novel glioma
invasion-associated candidate genes. Neuropathol Appl Neurobiol.
38:201–212. 2012. View Article : Google Scholar
|
|
25
|
Li L, Ying J, Li H, Zhang Y, Shu X, Fan Y,
Tan J, Cao Y, Tsao SW, Srivastava G, et al: The human cadherin 11
is a pro-apoptotic tumor suppressor modulating cell stemness
through Wnt/β-catenin signaling and silenced in common carcinomas.
Oncogene. 31:3901–3912. 2012. View Article : Google Scholar :
|
